Cytodyn OTC Stock Quote Today


USD 0.34  0.01  2.86%   

Market Performance
0 of 100
Odds Of Distress
Less than 42
Cytodyn is trading at 0.34 as of the 7th of December 2022; that is -2.86 percent decrease since the beginning of the trading day. The stock's open price was 0.35. Cytodyn has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Cytodyn are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of December 2021 and ending today, the 7th of December 2022. Click here to learn more.
CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people. The company has 813.04 M outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. More on Cytodyn
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Cytodyn OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cytodyn's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cytodyn or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cytodyn generated a negative expected return over the last 90 days
Cytodyn has high historical volatility and very poor performance
Cytodyn has some characteristics of a very speculative penny stock
The company currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M).
Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
CEO and President and DirectorNader Pourhassan
Average Analyst Recommendation
Analysts covering Cytodyn report their recommendations after researching Cytodyn's financial statements, talking to executives and customers, or listening in on Cytodyn's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Cytodyn. The Cytodyn consensus assessment is calculated by taking the average forecast from all of the analysts covering Cytodyn.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Cytodyn's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Cytodyn [CYDY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 280.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cytodyn's market, we take the total number of its shares issued and multiply it by Cytodyn's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cytodyn conducts business under Biotechnology sector and is part of Health Care industry. The entity has 813.04 M outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Cytodyn Probability Of Bankruptcy
Cytodyn retains a total of 813.04 Million outstanding shares. Cytodyn shows 8.1 percent if its outstanding shares held by insiders and 8.1 percent owned by other corporate entities . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Cytodyn Ownership Details

Cytodyn Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Cytodyn jumping above the current price in 90 days from now is about 87.64%. The Cytodyn probability density function shows the probability of Cytodyn otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Cytodyn has a beta of 0.7673 suggesting as returns on the market go up, Cytodyn average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cytodyn will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cytodyn is significantly underperforming NYSE Composite.
  Odds Below 0.34HorizonTargetOdds Above 0.34
12.31%90 days
Based on a normal probability distribution, the odds of Cytodyn to move above the current price in 90 days from now is about 87.64 (This Cytodyn probability density function shows the probability of Cytodyn OTC Stock to fall within a particular range of prices over 90 days) .

Cytodyn Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cytodyn market risk premium is the additional return an investor will receive from holding Cytodyn long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cytodyn. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cytodyn's alpha and beta are two of the key measurements used to evaluate Cytodyn's performance over the market, the standard measures of volatility play an important role as well.

Cytodyn Stock Against Markets

Picking the right benchmark for Cytodyn otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cytodyn otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cytodyn is critical whether you are bullish or bearish towards Cytodyn at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytodyn without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now


Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Cytodyn Corporate Directors

Cytodyn corporate directors refer to members of a Cytodyn board of directors. The board of directors generally takes responsibility for the Cytodyn's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cytodyn's board members must vote for the resolution. The Cytodyn board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Carl Dockery - DirectorProfile
Bruce Montgomery - Independent DirectorProfile
David Welch - DirectorProfile
Jordan Naydenov - Independent DirectorProfile

Invested in Cytodyn?

The danger of trading Cytodyn is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cytodyn is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cytodyn. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cytodyn is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.